PRGO — PERRIGO Co plc
—
NYSE ·
Health Care ·
Pharmaceuticals ·
CIK 1585364 ·
Last close
$14.27
Market Cap
$1.98B
52W High
$14.35
52W Low
$9.40
ADV30
2,824,891
Next earnings
2026-11-04
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 1,022,800,000 | 313,900,000 | 39,000,000 | 74,500,000 | 7,609,500,000 | 399,700,000 | 5,093,700,000 |
| Mar 2026 | — | — | — | — | — | — | — |
| Dec 2025 | 1,109,600,000 | 362,200,000 | 84,400,000 | -1,418,100,000 | 8,535,200,000 | 531,600,000 | 5,599,700,000 |
| Sep 2025 | 1,043,300,000 | 377,100,000 | 93,400,000 | 7,500,000 | 10,084,000,000 | 432,100,000 | 5,637,500,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$189,200,000
Investing CF
$-62,100,000
Financing CF
$-204,100,000
CapEx
$-81,700,000
Dividends Paid
$-158,600,000
Buybacks
—
EPS Diluted TTM
$-13.10
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$-4,001,900,000
Inventory
$1,064,500,000
Receivables
$709,900,000
ST Investments
—
EBIT TTM
$-1,449,300,000
Pretax Income TTM
$-1,612,400,000
Interest Exp TTM
$163,100,000
Analysts
4
Yahoo Snapshot (yfinance, live)
Total Revenue
$4,144,900,096
EBITDA
$615,500,032
Free Cash Flow
$437,212,512
Enterprise Value
$5,054,161,920
Total Cash
$399,700,000
Total Debt
$3,476,400,128
Shares Out
138,769,245
Trailing EPS
$-12.29
Book Value
$18.14
ROE
-48.7%
ROA
2.0%
Div Yield
8.14%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 4,253,100,000 | 312,800,000 | -1,425,400,000 | 8,535,200,000 | 5,599,700,000 | — | 238,500,000 |
| Dec 2024 | 4,373,400,000 | 311,900,000 | -171,800,000 | 9,647,700,000 | 5,328,300,000 | — | 362,900,000 |
| Dec 2023 | 4,655,600,000 | 284,100,000 | -12,700,000 | 10,809,100,000 | 6,041,200,000 | — | 405,500,000 |
| Dec 2022 | 4,451,600,000 | 121,400,000 | -140,600,000 | 11,017,300,000 | 6,175,200,000 | — | 307,300,000 |
TTM Snapshot
Revenues TTM
$4,354,200,000
NetIncome TTM
$-115,100,000
OpCashFlow TTM
$0
Assets (Latest)
$9,647,700,000
Forward EPS
$2.40
Max Pain — expiry 2026-11-20 (volume-derived — Yahoo OI feed degraded)
max pain strike: $12.50 · spot: $14.27 · call volume: 438 · put volume: 130
Expected Move to 2026-11-20:
±$3.55
(24.88%) —
implied range
$10.72 –
$17.82
· ATM straddle on $15.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| CMPS | COMPASS Pathways plc | $1.97B | $14.20 | — |
| AGIO | AGIOS PHARMACEUTICALS, INC. | $1.95B | $32.64 | — |
| NBTX | Nanobiotix S.A. | $2.01B | $39.66 | — |
| GHRS | GH Research PLC | $1.93B | $28.10 | — |
| ZYME | Zymeworks Inc. | $2.04B | $28.77 | — |
News headlines (Yahoo Finance, 1h cache)
Perrigo (PRGO) Q2 2026 Earnings Call Transcript
2026-08-12 13:59 · Yahoo
Perrigo (PRGO) In Focus As Q2 Earnings Beat Revives The Undervalued Narrative
2026-08-08 11:10 · Yahoo
Perrigo (PRGO) Surpasses Q2 Earnings and Revenue Estimates
2026-08-05 11:45 · Yahoo
This Under-the-Radar Healthcare Stock Yields Nearly 8.5%. Here's Whether That Income Is Too Good to Be True.
2026-08-22 21:35 · Yahoo
Perrigo Company plc Q2 2026 Earnings Call Summary
2026-08-05 22:45 · Yahoo
PRGO vs. NEOG: Which Stock Is the Better Value Option?
2026-08-10 15:40 · Yahoo
Are Investors Undervaluing Perrigo (PRGO) Right Now?
2026-08-10 13:40 · Yahoo
Perrigo (PRGO) Stock Trades At A Discount After A 62% Fall
2026-08-09 06:13 · Yahoo
Perrigo Q2 Earnings Call Highlights
2026-08-09 01:03 · Yahoo
Perrigo Stock Rises 23% as Q2 Earnings & Sales Beat Estimates
2026-08-06 18:24 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.